Currently, there are 600.40M common shares owned by the public and among those 494.29M shares have been available to trade.
The company’s stock has a 5-day price change of 2.73% and 46.72% over the past three months. MPW shares are trading 52.66% year to date (YTD), with the 12-month market performance up to 36.43% higher. It has a 12-month low price of $3.51 and touched a high of $6.55 over the same period. MPW has an average intraday trading volume of 13.49 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 9.75%, 24.21%, and 26.31% respectively.
Institutional ownership of Medical Properties Trust Inc (NYSE: MPW) shares accounts for 61.55% of the company’s 600.40M shares outstanding.
It has a market capitalization of $3.62B and a beta (3y monthly) value of 1.34. The earnings-per-share (ttm) stands at -$4.02. The company has a debt-to-equity ratio at 1.85. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.10% over the week and 4.43% over the month.
Earnings per share for the fiscal year are expected to increase by 102.21%, and -28.43% over the next financial year.
Looking at the support for the MPW, a number of firms have released research notes about the stock. Exane BNP Paribas stated their Outperform rating for the stock in a research note on March 12, 2025, with the firm’s price target at $5-$9. Colliers Securities coverage for the Medical Properties Trust Inc (MPW) stock in a research note released on September 13, 2024 offered a Buy rating with a price target of $6.50. Exane BNP Paribas was of a view on July 02, 2024 that the stock is Neutral, while Deutsche Bank gave the stock Hold rating on April 17, 2024, issuing a price target of $5. Colliers Securities on their part issued Neutral rating on April 10, 2024.
